Pfizer's withdrawal from the oral GLP-1 space leaves orforglipron without a near-term small-molecule competitor
Here, too, the evidence is lopsided
Serious cutaneous toxicities with immune checkpoint inhibitors in the U.S
Overexpression of CCS in G93A-SOD1 mice leads to accelerated neurological deficits with severe mitochondrial pathology
It was actually on Facebook and I was going through, I was just scrolling through and I found an ad and it was talking about, do you have access sweating and I had clicked on it and was looking around and I found that there was a procedure for Miradry, and I was looking around trying to find a place that was near my area and I happened to find thrive, and I wanted to see that that it was a, a, good clinic with good ratings
Among the most powerful compounds leading the charge